Business StandardCenter·
Q2 results, order win drive Symbiotec Pharma 20% higher to new high
Symbiotec Pharmalab's stock got listed on September 1 this year and has rallied 54 per cent from the IPO price of ₹988 apiece.
Read at Business Standard →
Business · 1 sources covering this
Q2 results, order win drive Symbiotec Pharma 20% higher to new high
Symbiotec Pharmalab's stock got listed on September 1 this year and has rallied 54 per cent from the IPO price of ₹988 apiece.
Coverage spectrum
0 L · 1 C · 0 R
How 1 sources are covering this
Embed this bias spectrum on your site
Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.
<iframe src="https://hindustansphere.com/embed/cluster/7cb6b7049609540b29b85d2b21f310ea3cf52484" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Q2 results, order win drive Symbiotec Pharma 20% higher to new high"></iframe>
